Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

NCT05206578 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

264

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: AGT2, AGZ
DRUG: AGT2
DRUG: AGT4, AGZ
DRUG: AGT4

Sponsor

Ahn-Gook Pharmaceuticals Co.,Ltd